Clinical Trial Update: Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease [Phase 1, Phase 2]

View source ↗

Summary

Describes a Phase 1/2 nonmyeloablative haploidentical peripheral blood stem cell transplantation approach for sickle cell disease. The trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-07